Articles with public access mandates - STEPHEN R MARDERLearn more
Not available anywhere: 10
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with …
JM Kane, CU Correll, DC Goff, B Kirkpatrick, SR Marder, ...
Journal of clinical psychiatry 70 (10), 1348, 2009
Mandates: US National Institutes of Health
A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
LF Jarskog, MT Lowy, RA Grove, RSE Keefe, JP Horrigan, MP Ball, ...
Schizophrenia research 164 (1-3), 136-142, 2015
Mandates: US National Institutes of Health, National Medical Research Council, Singapore
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies
M O’Donovan
J Clin Psychiatry 70 (1), 25-35, 2009
Mandates: US National Institutes of Health
Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study
AM Wessels, RR Bies, BG Pollock, LS Schneider, JA Lieberman, S Stroup, ...
The Journal of Clinical Pharmacology 51 (11), 1587-1591, 2011
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Motivational and cognitive factors linked to community integration in homeless veterans: study 1–individuals with psychotic disorders
MF Green, JK Wynn, S Gabrielian, G Hellemann, WP Horan, RS Kern, ...
Psychological Medicine 52 (1), 169-177, 2022
Mandates: US Department of Veterans Affairs
Older brains are different: brain–behavior studies and their CLinical UtiLity
DL Sultzer, SR Marder
The American Journal of Geriatric Psychiatry 25 (1), 11-12, 2017
Mandates: US Department of Veterans Affairs
Restrictive symptomatic inclusion criteria create barriers to clinical research in schizophrenia negative symptoms: an analysis of the CATIE dataset
E Dunayevich, CY Chen, SR Marder, J Rabinowitz
European Neuropsychopharmacology 24 (10), 1615-1621, 2014
Mandates: US National Institutes of Health
Motivational and cognitive factors linked to community integration in homeless veterans: Study 2–clinically diverse sample
JK Wynn, S Gabrielian, G Hellemann, WP Horan, RS Kern, J Lee, ...
Psychological Medicine 51 (16), 2915-2922, 2021
Mandates: US Department of Veterans Affairs
Examining racial differences in community integration between black and white homeless veterans
DM Novacek, JK Wynn, S Gabrielian, SM Glynn, G Hellemann, WP Horan, ...
Psychiatry Research 308, 114385, 2022
Mandates: US National Institutes of Health, US Department of Education, US Department …
Both typical and atypical antipsychotic agents were associated with increased risk for sudden cardiac death
S Marder
Annals of Internal Medicine 151 (8), JC2-12, 2009
Mandates: US National Institutes of Health
Available somewhere: 69
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ...
Nature 604 (7906), 502-508, 2022
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo, US National Institutes …
Rare coding variants in ten genes confer substantial risk for schizophrenia
T Singh, T Poterba, D Curtis, H Akil, M Al Eissa, JD Barchas, N Bass, ...
Nature 604 (7906), 509-516, 2022
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study
RS Kern, JM Gold, D Dickinson, MF Green, KH Nuechterlein, LE Baade, ...
Schizophrenia research 126 (1-3), 124-131, 2011
Mandates: US National Institutes of Health
Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial
KL Subotnik, LR Casaus, J Ventura, JS Luo, GS Hellemann, ...
JAMA psychiatry 72 (8), 822-829, 2015
Mandates: US National Institutes of Health
Clinical guidance on the identification and management of treatment-resistant schizophrenia
JM Kane, O Agid, ML Baldwin, O Howes, JP Lindenmayer, S Marder, ...
The Journal of clinical psychiatry 80 (2), 2783, 2019
Mandates: UK Medical Research Council
Schizophrenia—time to commit to policy change
WW Fleischhacker, C Arango, P Arteel, TRE Barnes, W Carpenter, ...
Schizophrenia bulletin 40 (Suppl_3), S165-S194, 2014
Mandates: Government of Spain
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
SG Potkin, JM Kane, CU Correll, JP Lindenmayer, O Agid, SR Marder, ...
NPJ schizophrenia 6 (1), 1, 2020
Mandates: UK Medical Research Council
KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia
RA Hauser, SA Factor, SR Marder, MA Knesevich, PM Ramirez, ...
American Journal of Psychiatry 174 (5), 476-484, 2017
Mandates: US National Institutes of Health
Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals
YCA Feng, DP Howrigan, LE Abbott, K Tashman, F Cerrato, T Singh, ...
The American Journal of Human Genetics 105 (2), 267-282, 2019
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder
AW Charney, DM Ruderfer, EA Stahl, JL Moran, K Chambert, ...
Translational psychiatry 7 (1), e993-e993, 2017
Mandates: US National Institutes of Health, Swedish Research Council, UK Medical …
Publication and funding information is determined automatically by a computer program